83 related articles for article (PubMed ID: 20466032)
1. Progress in metallocarboxypeptidases and their small molecular weight inhibitors.
Fernández D; Pallarès I; Vendrell J; Avilés FX
Biochimie; 2010 Nov; 92(11):1484-500. PubMed ID: 20466032
[TBL] [Abstract][Full Text] [Related]
2. Metallocarboxypeptidases: emerging drug targets in biomedicine.
Arolas JL; Vendrell J; Aviles FX; Fricker LD
Curr Pharm Des; 2007; 13(4):349-66. PubMed ID: 17311554
[TBL] [Abstract][Full Text] [Related]
3. Metallocarboxypeptidases and their inhibitors: recent developments in biomedically relevant protein and organic ligands.
Fernández D; Pallarès I; Covaleda G; Avilés FX; Vendrell J
Curr Med Chem; 2013; 20(12):1595-608. PubMed ID: 23432588
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase M: Multiple alliances and unknown partners.
Deiteren K; Hendriks D; Scharpé S; Lambeir AM
Clin Chim Acta; 2009 Jan; 399(1-2):24-39. PubMed ID: 18957287
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics and free energy studies on the carboxypeptidases complexed with peptide/small molecular inhibitor: mechanism for drug resistance.
Zhang H; Yao Y; Yang H; Wang X; Kang Z; Li Y; Li G; Wang Y
Insect Biochem Mol Biol; 2012 Aug; 42(8):583-95. PubMed ID: 22549081
[TBL] [Abstract][Full Text] [Related]
6. Cyclobutane-containing peptides: evaluation as novel metallocarboxypeptidase inhibitors and modelling of their mode of action.
Fernández D; Torres E; Avilés FX; Ortuño RM; Vendrell J
Bioorg Med Chem; 2009 Jun; 17(11):3824-8. PubMed ID: 19414265
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
9. [Partial characteristics of the basic phenylmethylsulfonylfluoride-inhibited carboxypeptidase from cat brain].
Vernigora AN; Nikishin NN; Gengin MT
Biokhimiia; 1995 Nov; 60(11):1860-6. PubMed ID: 8590758
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
11. Characterization and cDNA cloning of midgut carboxypeptidases from Trichoplusia ni.
Wang P; Li G; Kain W
Insect Biochem Mol Biol; 2004 Aug; 34(8):831-43. PubMed ID: 15262287
[TBL] [Abstract][Full Text] [Related]
12. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties.
Vendrell J; Querol E; Avilés FX
Biochim Biophys Acta; 2000 Mar; 1477(1-2):284-98. PubMed ID: 10708864
[TBL] [Abstract][Full Text] [Related]
13. TAFIa inhibitors in the treatment of thrombosis.
Bunnage ME; Owen DR
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):480-6. PubMed ID: 18600565
[TBL] [Abstract][Full Text] [Related]
14. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
Njoroge FG; Chen KX; Shih NY; Piwinski JJ
Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B.
Adler M; Bryant J; Buckman B; Islam I; Larsen B; Finster S; Kent L; May K; Mohan R; Yuan S; Whitlow M
Biochemistry; 2005 Jul; 44(26):9339-47. PubMed ID: 15982000
[TBL] [Abstract][Full Text] [Related]
16. Recent patents in the discovery of small molecule inhibitors of JAK3.
Wilson LJ
Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
[TBL] [Abstract][Full Text] [Related]
17. Two metallocarboxypeptidases from the protozoan Trypanosoma cruzi belong to the M32 family, found so far only in prokaryotes.
Niemirowicz G; Parussini F; Agüero F; Cazzulo JJ
Biochem J; 2007 Jan; 401(2):399-410. PubMed ID: 17007610
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of binding sites in metallocarboxypeptidases based on Optimal Docking Area analysis.
Fernández D; Vendrell J; Avilés FX; Fernández-Recio J
Proteins; 2007 Jul; 68(1):131-44. PubMed ID: 17407161
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
20. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.
Reverter D; Fernández-Catalán C; Baumgartner R; Pfänder R; Huber R; Bode W; Vendrell J; Holak TA; Avilés FX
Nat Struct Biol; 2000 Apr; 7(4):322-8. PubMed ID: 10742178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
